IL6 and cancer: The patient group with high serum IL-6 levels had a poor prognosis, supporting previous results [5]. Several studies have suggested that IL-6 is positively correlated with advanced stages of cancer, especially T stage in patients with OSCC, indicating its association with clinical factors.